IFM Global Infrastructure Fund has declared its $5.10 per security offer for Atlas Arteria (ASX:ALX) unconditional and best-and-final, removing all remaining conditions while the company’s independent directors maintain their unanimous rejection of what they characterise as an opportunistic bid that materially undervalues the toll-road operator.
Atlas Arteria shares have converged toward the $5.10 offer price following IFM’s removal of all prescribed occurrences conditions under section 650F of the Corporations Act. The stock is trading with minimal spread to the bid, reflecting markets’ assessment of high deal certainty despite the board’s opposition. The offer represents an 18 percent premium to the undisturbed price of $4.33 and a similar premium to the one-month volume-weighted average price of $4.28 recorded prior to the initial approach.
IFM’s voting power in Atlas Arteria now stands at 38.42 percent, a substantial increase from its initial toehold position. The infrastructure fund has backed its best-and-final declaration with a truth-in-takeovers statement, committing not to acquire ALX securities above $5.10 for 12 months absent a competing proposal. The offer is scheduled to close at 7:00pm Sydney time on 25 June 2026 and will not be extended unless required by law.
Chicago Skyway Valuation
IFM has framed its $5.10 bid as implying a Chicago Skyway valuation consistent with Atlas Arteria’s 2022 acquisition price and above current book value. The Chicago Skyway toll road represents a significant component of ALX’s portfolio, and IFM argues its offer appropriately values this asset given that Ontario Teachers’ Pension Plan recently rejected Atlas Arteria’s right-of-first-offer at a similar valuation level. The total equity value implied by the offer stands at approximately $7.4 billion.
Top Australian Brokers
- Pepperstone - Top Australian broker - Read our review
- eToro - Invest in ASX and international shares - Read our review
Atlas Arteria’s portfolio comprises stakes in major toll road assets including the APRR network in France, the Dulles Greenway in Virginia, and the Chicago Skyway concession. The company has maintained distribution guidance of 40 cents per security for 2026, with management highlighting the long-duration, inflation-linked cash flows embedded in its concession agreements.
The independent directors issued their third supplementary target’s statement in mid-June, reiterating their recommendation that securityholders reject the offer. The board has consistently argued that IFM’s bid fails to capture the intrinsic value of Atlas Arteria’s asset base, growth trajectory, and distribution capacity over the long term.
Competing Bid Absent
Despite weeks of public contest over a portfolio of core infrastructure assets, no alternative bidder has formally emerged as of mid-June 2026. The absence of a competing proposal represents a significant challenge to the board’s narrative that the company is worth materially more than $5.10 per security.
IFM’s best-and-final statement effectively caps near-term upside for event-driven holders unless a competing bidder surfaces before the 25 June deadline. The infrastructure fund’s commitment not to pay above $5.10 for 12 months removes the possibility of a gradual creep strategy at higher prices, creating a clear decision point for securityholders weighing certain cash today against uncertain standalone prospects.
What Next?
If IFM’s offer closes with moderate acceptance levels, Atlas Arteria faces the prospect of operating with a dominant 40-50 percent blockholder that has publicly stated its view that current pricing fully values the business. This scenario could create governance tensions and potentially depress the share price below $5.10 as event-driven capital exits and long-only holders reassess the implications of a controlled-but-not-wholly-owned structure.
Alternatively, if acceptance levels push IFM’s stake materially higher toward control thresholds, markets would likely maintain support near the offer price in anticipation of eventual compulsory acquisition or scheme processes. The unconditional nature of the bid provides a firm floor for acceptances, reducing execution risk for those choosing liquidity over continued exposure.
The unconditional status removes deal completion risk for those accepting, but introduces post-closing uncertainty for those who reject and remain as minority holders in a company with a dominant shareholder advocating for conservative valuations. Markets will watch acceptance levels closely as the 25 June deadline approaches, with the outcome determining whether this hostile contest ends in effective control for IFM or an extended period of shareholder tension.
